Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
FP01 - Early Stage/Localized Disease/Ablative Therapies
- Type: Posters (Featured)
- Track: Early Stage/Localized Disease/Ablative Therapies
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP01.03 - Prevalence, Treatment Patterns and Long-Term Clinical Outcomes of Patients with EGFR Positive Resected Stage IB-IIIA NSCLC
00:00 - 00:00 | Presenter: Sabine Schmid
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
FP04 - Immunotherapy (Phase II/III Trials)
- Type: Posters (Featured)
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP04.01 - Nivolumab 480 mg Every 4 Weeks as De Novo Second-line Treatment for Advanced Non-Small Cell Lung Cancer: CheckMate 907
00:00 - 00:00 | Presenter: Natasha Leighl
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
FP12 - Predictive Tumor Based Assays/Biomarkers/Pathology
- Type: Posters (Featured)
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 8
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP12.01 - PD-L1 Assessment in Cytology is Comparable to Histology in Predicting Treatment Response to Checkpoint Inhibitors in NSCLC
00:00 - 00:00 | Presenter: Sally CM Lau
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
FP12.07 - Clinico-demographic Factors, EGFR status and their association with Stage at Diagnosis in Lung Adenocarcinoma Patients
00:00 - 00:00 | Presenter: Joshua E Herman
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 18
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P45.05 - Sequencing of PD-1 Inhibitors and TKIs in Metastatic NSCLC with MET Exon 14 Skipping Mutation May Influence Survival
00:00 - 00:00 | Presenter: Sally CM Lau
- Abstract
Loading... -
+
P45.07 - Real-World Clinically-Relevant Toxicities of ALK TKIs in a Cohort of Patients With Advanced/Metastatic ALK+ NSCLC
00:00 - 00:00 | Presenter: Sabine Schmid
- Abstract
Loading... -
+
P45.09 - Real-World Sequencing of ALK-TKIs in Advanced Stage ALK-positive NSCLC patients in Canada
00:00 - 00:00 | Presenter: Simren Chotai
- Abstract
Loading...
-
+
P48 - Novel Therapeutics and Targeted Therapies - EGFR
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 17
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P48.05 - Is Relapse-Free Survival at 2-Years an Appropriate Surrogate for Overall Survival at 5-Years in EGFR-mutated Resected NSCLC?
00:00 - 00:00 | Presenter: Miguel Garcia
- Abstract
Loading...
-
+
P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 32
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P59.17 - EGFR Mutation Status, Liver Metastasis, and Overall Survival in Advanced Lung Adenocarcinoma Patients
00:00 - 00:00 | Presenter: Preet Walia
- Abstract
Loading...
-
+
OA08 - Moving Beyond New Drugs: What Else Matters?
- Type: Oral
- Track: Health Services Research/Health Economics
- Presentations: 6
- Moderators:Upal Basu Roy
- Coordinates: 9/09/2021, 09:30 - 10:30, Program Auditorium
-
+
OA08.04 - Validation of Scalable, Automated Data Extraction in an Advanced Lung Cancer Patient Population
10:00 - 10:10 | Presenter: Marie-pier Gauthier
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA08 - Driver Mutations and Immune Profiles in Early Stage NSCLC
- Type: Mini Oral
- Track: Early Stage/Localized Disease/Ablative Therapies
- Presentations: 8
- Coordinates: 9/09/2021, 12:00 - 13:00, Program Auditorium
-
+
MA08.02 - Outcomes of Early Stage ALK-positive NSCLC Patients in a Real-World Cohort
12:05 - 12:10 | Presenter: Sabine Schmid
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future
- Type: Mini Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Presentations: 8
- Coordinates: 9/12/2021, 20:00 - 21:00, Program Auditorium
-
+
MA12.03 - A Thoracic Cancers International COVID 19 Collaboration Survey on Patients’ Perceptions of COVID-19 (Teravolt-Paper)
20:10 - 20:15 | Presenter: Selina K Wong
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA16 - Clinical Impact of Liquid Biopsy for Patients with NSCLC
- Type: Oral
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
- Presentations: 6
- Moderators:Sarah B Goldberg
- Coordinates: 9/12/2021, 20:00 - 21:00, Program Auditorium
-
+
OA16.02 - The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer
20:10 - 20:20 | Presenter: Doreen Ezeife
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
